Cargando…
A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy
In formerly healthy females, acute heart failure (HF) of an unknown cause that develops during the last weeks of gestation or in the first months after childbirth is known as peripartum cardiomyopathy (PPCM). This study aimed to establish the therapeutic value of combining bromocriptine with convent...
Autores principales: | Badianyama, Marheb, Das, Prasanta K, Gaddameedi, Sai Rakshith, Saukhla, Sonia, Nagammagari, Tejaswini, Bandari, Vandana, Mohammed, Lubna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475739/ https://www.ncbi.nlm.nih.gov/pubmed/34603902 http://dx.doi.org/10.7759/cureus.18248 |
Ejemplares similares
-
Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
por: Simon, Rebecca, et al.
Publicado: (2018) -
Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012) -
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017) -
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018) -
An Interesting Case of Peripartum Cardiomyopathy With Biventricular Thrombi
por: Abi Jaoude, Joseph, et al.
Publicado: (2023)